The Effects of Dietary Tryptophan on Affective Disorders
Glenda Lindseth a,⁎, Brian Helland a, Julie Caspers b a University of North Dakota, Grand Forks, ND b Northland Community and Technical College, Bemidji, MN
a b s t r a c t
Using a randomized crossover study design, 25 healthy young adults were examined for differences in anxiety, depression, and mood after consuming a high tryptophan and a low tryptophan diet for 4 days each. There was a 2 week washout between the diets. A within-subjects analysis of the participants’ mood indicated signif- icantly (p b .01) more positive affect scores after consuming a high tryptophan diet as compared to a low trypto- phan diet. Negative affect differences between the diets were not statistically significant (p N .05). Also, consuming more dietary tryptophan resulted in (p b .05) less depressive symptoms and decreased anxiety.
© 2014 Elsevier Inc. All rights reserved.
Tryptophan, an essential amino acid, is a precursor of serotonin syn- thesis. The synthesis of serotonin from tryptophan derives from a two- step process with the rate of serotonin synthesis dependent on trypto- phan concentrations in the brain (Fernstrom, 2013). Because serotonin is involved in the regulation of mood and anxiety, low brain serotonin levels may contribute to increased anxiety and depression (Fernstrom, 2013; Hakkarainen et al., 2003; Robinson, Cools, Crockett, & Sahakian, 2010). However, tryptophan is obtained through diet because it cannot be synthesized by the body (Soh &Walter, 2011); and as a result, “die- tary factors that influence the blood levels of tryptophan and other amino acids can modify tryptophan uptake in the brain, and conse- quently the rate of serotonin formation” (Fernstrom, 1985). However, dietary consumption of tryptophan has been questioned as having an effect on anxiety, depression, or mood, especially in healthy individuals (Fernstrom, 2013; Soh & Walter, 2011; Wurtman & Wurtman, 1995). Therefore, this study examined the effects of high dietary tryptophan and low dietary tryptophan on anxiety, mood, and depression scores in a healthy adult population.
TRYPTOPHAN, MOOD, AND ANXIETY
As the availability of serotonin depends on the intake of tryptophan, dietary sources of this amino acid are seen as essential for good mental health and well-being. However, study results are mixed regarding the effects of tryptophan levels on mood and anxiety. For example, plasma tryptophan and mood levels of 50 healthy women were compared fol- lowing a 3-week, protein-sparing 1000 kcal diet, with a final week of being randomly allocated to receive either dietary tryptophan or a pla- cebo (Attenburrow et al., 2003). Profile of Mood States (POMS) testing on the final day of the diet showed no change in mood (Attenburrow et al., 2003). In another long-term study, more than 29,000 Finnish
men ages 50–69 years were assessed over a 5- to 8-year period using a self-report dietary history questionnaire to determine amino acid con- sumption of the participants’ self-reported depression andmood. No as- sociations were found between tryptophan intake and depression and mood (Hakkarainen et al., 2003).
The effects of tryptophan supplementation on the mood of healthy participants were also tested in another study (Markus, Firk, Gerhardt, Kloek, & Smolders, 2008). Although the same quantities of tryptophan were given to participants, significant improvements in mood were seen only in participants supplemented with a protein hydrolysate and pure tryptophan in comparison to other tryptophan supplementa- tion (Markus et al., 2008).
Another study focused on the use of a high tryptophan diet (50 mg/kg/d) alongwith a carbohydrate diet to improve smoking absti- nence. Sixteen participants were randomly assigned to receive trypto- phan and 15 participants received a placebo in addition to group therapy sessions. Anxiety symptoms were lower in the tryptophan group compared to the control group (Bowen, Spring, & Fox, 1991).
Tryptophan Depletion, Mood and Depression
In studies examining the effects of tryptophan depletion on mood and depression, results have been consistent (Ruhé, Mason, & Schene, 2007). For example, in a meta-analysis of studies from 1966 through 2006, tryptophan depletion showed decreased mood states in partici- pants with major depressive disorders, with a family history of depres- sive disorders, or with major depressive disorders in remission (Ruhé et al., 2007). However, there was no effect on the mood of healthy par- ticipants who were subjected to tryptophan depletion.
Other authors have reached similar conclusions (Neumeister et al., 1998; Spillmann et al., 2001). For example, in a double-blinded cross- over study, eleven recovered patients with a history of depression and who had suffered from recurrent seasonal affective disorder were ran- domly assigned to receive beverages with and without tryptophan. The tryptophan depleted beverages caused a transient recurrence of
Archives of Psychiatric Nursing 29 (2015) 102–107
⁎ Corresponding Author: Glenda Lindseth, RN, PhD, FAAN, FADA, Professor of Nursing, 430 Oxford, Stop 9025, University of North Dakota, Grand Forks, ND 58202.
E-mail addresses: email@example.com (G. Lindseth), firstname.lastname@example.org (B. Helland), Julie.email@example.com (J. Caspers).
http://dx.doi.org/10.1016/j.apnu.2014.11.008 0883-9417/© 2014 Elsevier Inc. All rights reserved.
Contents lists available at ScienceDirect
Archives of Psychiatric Nursing
j ourna l homepage: www.e lsev ie r .com/ locate /apnu
depressive symptoms (Neumeister et al., 1998). Because no healthy participants were included in the sample, this could be construed as a shortcoming of the study (Neumeister et al., 1998). Spillmann et al. con- ducted a double-blind, crossover study involving ten formerly de- pressed patients and found that tryptophan depletion correlated significantly with increased depression and anxiety scale scores. Both clinician-rated questionnaires and self-rating depression and anxiety scales had been used to measure the results (Spillmann et al., 2001).
In another study, tryptophanwhey-rich protein products were com- pared to placebo in 23 recovered depressed patients and 20 matched controls (Booij, Merens, Markus, & Van der Does, 2006). While there was significant improvement in the mood states of the tryptophan product compared to the placebo, only those individuals who had expe- rienced depression in the past suffered from negative mood changes when tryptophan was depleted.
Enhanced Tryptophan Consumption and Depression
In a 3-week randomized, crossover clinical trial, 30 institutionalized, elderly Malaysian residents consumed a cultural food (Talbinah). The authors identified Talbinah as high in tryptophan and assessed it for ef- fects on depression, stress, and anxiety levels of the participants (Badrasawi, Shahar, Abd, & Haron, 2013). The residents were interviewed and measured in weeks 0, 3, 4, and 7. One group was ran- domized into a control group and consumed the food provided to themby the long-term care facility they lived in. The other group served as the intervention group and was served Talbinah once per day. Study results indicated that depression and stress were reduced and mood was significantly enhanced (p b .05) after consumption of the high tryp- tophan food (Badrasawi et al., 2013). The authors concluded that high tryptophan foods, such as Talbinah, may have behavioral benefits for the older adults.
Sylvia, Peters, Deckersbach, and Nierenberg (2013) identified 23 studies published from1960 to 2011 that focused on the future possibil- ity of using nutrient-based treatments to help alleviate manic–depres- sive disorders (Sylvia et al., 2013). Of these, one involved enhanced tryptophan consumption (Chouinard, Young, & Annable, 1985). The Chouinard et al. (1985) study was an earlier unpublished study that was conducted as a two-phase trial involving 24 participants with mania who consumed large doses of an L-tryptophan amino acid over a 2 week period. Using the Clinical Global Inventory, the authors found that severity of symptoms was significantly reduced in the tryp- tophan group (Chouinard et al., 1985). Sylvia et al. (2013) recommend- ed further study of nutrient-based treatments, especially since published studies related to depression disorders and tryptophan were extremely limited (Sylvia et al., 2013).
Little evidence is available on the effects of diet on mood or depres- sive symptoms. Soh andWalter (2011) have explained that it is difficult to change plasma tryptophan levels through diet alone; therefore, most studies have focused on tryptophan supplementation and depletion (Markus et al., 1998, 2008; Mitchell et al., 2011). Very few publications have described the effect of consuming dietary foods and depression, al- though a study of elderly Malaysian residents conducted by Badrasawi et al. (2013) is an exception. Another group examined tryptophan de- pletion and its effect on mood but identified no changes in mood (Attenburrow et al., 2003). In previous study reports, dietary consump- tion of tryptophan produced notable effects in those individuals who suffered from neuropsychological disorders or had a history of such dis- orders, rather than in healthy individuals (Markus et al., 2008; Neumeister et al., 1998). Also, those studies involved the use of trypto- phan supplementation or manufactured nutrient powders rather than actual study meals. Although existing results are mixed, further study of nutrient-based treatments has been recommended because of the
potential impact and benefits on human health as a whole (Sylvia et al., 2013). Therefore, the purpose of this study was to examine the ef- fects of high dietary tryptophan and low dietary tryptophan on anxiety, mood, and depression scores in a healthy population.
RESEARCH DESIGN AND SAMPLING METHODS
Twenty-five participants were recruited into a within-subjects crossover-designed study. The participants were randomized to receive two 4-day dietary treatments; one was a low tryptophan diet (b5 mg/kg body weight/d) and one was a high tryptophan diet (N10 mg/kg body weight/d). There was a randomization of treatment order so all participants did not receive the same diets at the same time, and to prevent an error of variance. To prevent carry-over effects from the intervention diets, 2-week “washout” periods were included between the intervention diets. Differences among the participants’ anx- iety, mood, and depression scores were then analyzed following their consumption of both the high and low tryptophan diets. A double- blinded intervention plan resulted in neither the participant nor the re- searcher conducting the psychological tests knowing when the partici- pant received the high and the low tryptophan treatment diets.
Population Description and Sampling Plan
Using the following selection criteria, 25 healthy young men and women who consented to participate in the study, were randomly se- lected from 700 professional studies students at a midwestern universi- ty. The participants: (1) were in their third term of university study; (2) gave informed consent to participate in the study; (3) were over 18 years of age; and (4) were proficient in reading, speaking and comprehending the English language.
A power analysis was based upon a population mean for the Zung’s depression and anxiety scales used in this study and in previous work. Using Borenstein, Rothstein, and Cohen’s (2001) “Power & Precision” software (2001), the statistical power was calculated at .70 with a 5% level of significance and a “medium” effect size. Statistical power calcu- lations were based upon using paired t-test analyses. Possible effects of the dietary interventions were based on information gathered in a pre- liminary study of dietary intakes and using a similar study population. In addition, a pilot study was conducted with eight participants who were recruited to determine psychometric properties of the study in- struments, test study procedures and instrumentation, and to refine study protocols.
Research participants received a small compensation of $25 per week for their time in the study and as an expression of appreciation for contributing to the body of research knowledge. The U.S. Army Human Research Protection Office and the University’s Institutional Re- view Board reviewed and approved the study’s protocols. This was a re- quirement of the project’s funding agency. Participants were assured of their right to refuse to participate without prejudice and that their re- sponses would be kept confidential. Study data was summarized prior to being reported.
This within-subjects study was planned to determine differences in anxiety, mood, and depression scores of participants receiving high and low tryptophan diets. The low tryptophan diet contained 5 mg/kg body weight/d of tryptophan. This amount of tryptophan was based on the U.S. Recommended Daily Allowance (US RDA) of tryptophan (Food & Nutrition Board, 1989). The high tryptophan diet contained twice the US RDA for tryptophan (10 mg/kg body weight/d). Participants were served meals that met their required kilocalorie levels so that the participants’ would not lose weight, feel hungry or be over-fed. Their individual energy
103G. Lindseth et al. / Archives of Psychiatric Nursing 29 (2015) 102–107
(kilocalorie) requirements were determined by indirect calorimetry. Also, tomitigate unplanned effects arising frompossiblemicronutrient deficien- cies, study meals were planned to meet the US RDA within a 5% variance.
During an initial meeting with the study dietitian, eating schedules for each participant were determined. Weekends were also excluded to prevent logistical disruptions for both the participants and the re- searchproject. A 2weekwashout period separated the dietary interven- tions. Tryptophan levels were calculated according to each participant’s individual bodyweight for the first day of each study week. A variety of foods containing tryptophan were served, including mozzarella cheese, soy products, pumpkin seeds, and egg whites.
The preparation and consumption of study foods were closely mon- itored by the research team to ensure strict compliancewith consuming the study foods. The study meals were planned by the registered dieti- tian in consultation with the principal investigator. Portion sizes of the prescribed foodswereweighed before and after eating under the super- vision of the studydietitian.Weighing study foods and beverages is con- sidered themost precisemethod of measuring the food consumption of an individual (Gibson, 1990).
The study dietswere served in an on-campus, centrally located,met- abolic dining area. The dining space was arranged within a behavioral research facility to provide a controlled environment for serving study meals. Meals were served by research team members and participants were reminded of the importance of compliance with study protocols to consume only study foods and beverages. Participants were told that non-compliance could result in being eliminated from the study.
The beverages served included water and non-caloric and calorie- containing drinks such as milk and assorted fruit juices. Caffeine intake was limited to no more than 100 mg of caffeine per day to avoid con- founding effects. Participants could consume as much water as desired with all beverages measured and recorded to the nearest one-tenth of a fluid ounce. Participants were provided with bottled water. All bottles and any remaining contents were to be returned so accurate amounts of each participant’s consumed foods and beverages could be weighed and recorded.
Each day, the participants verified in writing that no other foods or beverages had been consumed during the previous 24 hours other than those issued by the study. All foods were eaten in the study’s met- abolic dining room except for the weighed snacks given to the study participants to consume during the evening to sustain the participants until morning.
TESTS AND MEASUREMENT
Data collected during the study included the following participant measurements:
Demographics are composed of the following variables: place of res- idence, age, employment status, years of education,marital/social living status, ethnicity, and anthropometricweight and heightmeasurements. Body mass indices (BMI) were also calculated.
Salivary cortisol was measured because it has been shown to reflect changes in mood (Markus, Panhuysen, Tuiten, & Koppeschaar, 2000). A cortisol Salivette© swab, placed in each participant’s mouth under the tongue, was used to collect the saliva specimens.
Zung’s Self-Rating Anxiety Scale (Zung, 1965) was used to evaluate and quantify 20 items as they applied to the participant’s anxietywithin the past 24 hours. Degrees of anxiety were scored using the following values: none of the time = 1; some or a little of the time (mild) = 2; goodpart of the time (moderate)=3;most or all of the time (severe)= 4. An index score was obtained by dividing the sum of all scores of the 20 items by a maximum possible score of 0.8. Alpha reliabilities ranged from 0.61 to 0.80 as “substantially” reliable in previous studies (Bucky & Spielberger, 1973). Zung established the validity of the instrument through previous correlation comparisons of 96 age-matched normal participants using the Taylor Manifest Anxiety Scale (Zung, 1973). For this study, the Self-Rating Anxiety Scale had a reliability of alpha = .85.
Zung’s Self-Rating Depression Scale (SDS) was used to measure the participant’s depression symptoms. The Zung SDS is a 20-item scale de- veloped from interview data of patients who exhibited various depres- sive symptoms (Zung, 1965, 1986; Zung, Richards, & Short, 1965). Each itemhas a scoring range from1 (least depressed) to 4 (most depressed). The reliability of Zung’s SDSwas alpha= .91 for this study and alpha= .85 for depressionmeasurements of a sample of 415 undergraduate stu- dents (Campbell, Maynard, Roberti, & Emmanuel, 2012). Concurrent va- lidity for the Zung SDS was established with the Minnesota Multiphasic Personality Inventory (MMPI). Based on depression measures for 152 patients, a correlation coefficient of .70 was obtained between the Zung SDS and MMPI Depression Scales (Zung, 1967).
Mood was measured using the PANAS (Positive Affect Negative Affect Schedule) (Watson, Clark,&Tellegen, 1988). Ten itemsassessedpositive af- fect or mood (e.g., excited), and 10 items measured negative affect or mood (e.g., irritable). A state measure of mood was assessed by having the participants indicate “to what extent do you feel this way right now” (Watson et al., 1988). Their answers ranged from 5 (extremely) to 1 (very slightly or not at all). The PANAS scale scored acceptably high alpha reliabilities, ranging from .86 to .90 for Positive Affect and from .84 to .87 for Negative Affect in 101 undergraduate students (Watson et al., 1988). In addition to these 20 items from the PANAS, 40 items were added from the expanded PANAS (PANAS-X) to measure irritability. Re- search set the internal consistency of the positive andnegative affect scales at alpha = .90 in a study of 328 participants (Watson & Clark, 1994).
A Health Status Assessment checklist, modified from Doenges’s (1989) Health Assessment Checklist, consisted of nine factors ascertained during a medical assessment of the participants. A history of diabetes, heart disease, hypertension, respiratory insufficiency, meta- bolic or gastrointestinal disorder, and urinary or neurological disorder was assessed and recorded for each study participant by the research nurse. Diabetes and pregnancy were exclusion factors for this study be- cause of the special dietary requirements that are necessary for prenatal and diabetic conditions. The participants’medication intakes and health status assessments were also used to identify conditions that might compromise performance outcomes.
PLAN FOR DATA COLLECTION AND ANALYSIS
Plan for Data Collection
During an initial meeting, potential participants who met the study’s inclusion criteria were invited to be in this study. The study’s purpose and participation details were explained and questions answered by the investigators. Those who consentedmet with the research nurse to com- plete demographic questionnaires and baseline health assessments. Height and weight measurements were taken during the baseline week and on the first day and last day of the treatment weeks. Directions for completing the dietary interventions and laboratory and psychological testswere then explained. Each participantwas assigned an eating sched- ule that accommodated their academic and/orwork schedules within the serving times of 6:30 a.m. and 6:30 p.m. During arranged eating times for the tryptophan intervention weeks, each participant was served meals weighed and measured to within one tenth of an ounce of accuracy for each food item. Each participant was monitored to ensure their meals were eaten and that food intakes were weighed and recorded accurately. On the fourth day of receiving each of the high and low dietary trypto- phan meals, respectively, each participant met with the psychologist for testing. Each participant received a $25 stipend per study week for time and inconvenience and as an expression of appreciation for themeaning- ful contribution each individual made to the research.
Data Entry and Analysis
Studydatawere entered into and analyzed using the Statistical Pack- age for Social Sciences (SPSS). Data were confirmed through a double
104 G. Lindseth et al. / Archives of Psychiatric Nursing 29 (2015) 102–107
entry procedure to further reduce error rates. Frequencies were tabulat- ed for responses to demographic questions andmeasures of anxiety, de- pression, andmood (irritability). Statistical significancewas set at alpha ≤ .05. Paired-sample t-tests and analysis of variance were used to com- pare participants’ anxiety, mood, and depression scores following high and low dietary tryptophan intakes. The ESHA Food Processor Nutrition Analysis Software© programwas used to analyze the nutritional content of the weighed food and beverage intakes that were served to each par- ticipant (E.S.H.A. Research, 2010). The nutrients selected for assessment and analysis were based on the US RDA (Food & Nutrition Board, 1989).
The study participants’ average age was 20.5 years (SD = 1.6), and they had 13.9 years of education (SD = 0.8). BMI averaged 23.5 (SD= 2.9) for all participants (see Table 1).
Effects of Tryptophan Consumption on Anxiety
Zung’s Self-Rating Anxiety Scale scores were analyzed following the participants’ consumption of high and low dietary tryptophan (see Table 2). Using a paired-sample t-test, anxiety scores were significantly lower (paired t = 2.2, p = .04) when the participants had consumed high tryptophan in comparison towhen they had consumed low trypto- phan. Self-Rating Anxiety scores showed significant improvement in participants who consumed more dietary tryptophan.
Effects of Tryptophan Consumption on Mood
The PANAS basic positive and negative affect scale (mood) scores and irritability scores for the participants consuming high tryptophan and low tryptophan intakes are displayed in Table 2. Participants had significantly higher positive affect (mood) scores (paired t = 2.8, p = .01)when consuminghigh dietary tryptophan thanwhen the samepar- ticipants consumed low dietary tryptophan. The PANAS basic negative affect scale (mood) scores for the participants consuming high trypto- phan and low tryptophan intakes were also not significantly different (p N .05). The Undergraduate Affective Irritability Subscale (Sakamoto, Kijima, Tomoda, & Kambara, 1998; Zung, 1965) scores were analyzed following the participants’ consumption of high and low dietary trypto- phan intakes. Using a paired-sample t-test, irritability scores trended higher (paired t = 2.03, p= .05) when the participants had consumed a low tryptophan diet in comparison towhen they had consumed a high tryptophan diet.
Effects of Tryptophan Consumption on Depression
Using Zung’s SDSDepression Scale, participants’meandepression scale scoreswere calculatedwhen the participants consumed high dietary tryp- tophan and when they consumed low tryptophan (see Table 2). Partici- pants were not clinically depressed upon entry into the study. However, awithin-subjects analysis of participants’ depression scale scores indicated they reached thresholds for depression (paired t = 2.2, p = .02) after
consuming less dietary tryptophan in comparison to when there was more tryptophan in their diet.
Effects of Tryptophan Consumption on Salivary Cortisol
Salivary cortisol swabs were taken and analyzed following the par- ticipants’ consumption of the high dietary tryptophan diet and the low dietary tryptophan diet (see Table 2). The cortisol swabs were taken at the end of both of the treatment weeks for all participants. The cortisol lab values were not significantly different (p N .05) when comparing the saliva samples.
The results of this double-blinded, within-subjects study indicate that participants consuming higher levels of tryptophan (N10 mg/kg body weight/d) had significantly less depression and irritability and de- creased anxiety than when they consumed lower levels of tryptophan (b5 mg/kg body weight/d). This finding may be explained by other re- sults indicating that dietary tryptophan can affect serotonin neurotrans- mitter levels in the brain, and in turn, influence the occurrence of depressive behavior in participants (Badrasawi et al., 2013). Also, earlier work has shown that serotonin-releasing neurons typically release neu- rotransmitters at levels determined by nutritional intakes (Wurtman & Wurtman, 1995). In addition, unlike similar studies showing that high tryptophan levels dampen salivary cortisol levels (Markus et al., 2000), we found no significant differences in cortisol lab values when comparing the saliva samples.
Although other tryptophan researchers have hypothesized that tryptophan consumed as a dietary food itemwould not have significant effects on affective mood states in healthy individuals (Fernstrom, 2013), an analysis of healthy participants in our study showed that higher doses of tryptophan consumed in dietary foods resulted in signif- icantly (p b .05) less depression and irritability and decreased anxiety. Similarly, in a study of 30 older Malaysian residents who consumed a high tryptophan native food over several weeks the residents experi- enced benefits related to mood, depression, stress, and anxiety levels (Badrasawi et al., 2013). However, our results differed from those of Attenburrow et al. (2003), who compared consumption of nutritionally sourced tryptophan (1.8 g daily) to a placebo in aweight loss study, and found no significant changes in the participants’ mood (Attenburrow et al., 2003).
Table 1 Participant Demographics.
Variables Mean SD
Demographics Age (years) 20.5 1.6 Education (years) 13.9 0.8 Body mass index 23.5 2.9
NOTE. N = 25.
Table 2 Within-Subject Differences for High and Low Dietary Tryptophan Intake.
Variable Mean SD Paired t-test p
Anxiety Low tryptophan 38.0 6.5 N 2.2 .04⁎ High tryptophan 35.9 5.7
Positive affect Low tryptophan 16.6 4.1 N 2.8 .01⁎⁎ High tryptophan 18.8 3.5
Negative affect Low tryptophan 7.8 2.5 N .92 N.S. High tryptophan 7.5 1.8
Irritability Low tryptophan 35.3 11.6 N 2.0 .05⁎ High tryptophan 31.7 7.9
Depression Low tryptophan 39.6 8.3 N 2.2 .02⁎ High tryptophan 37.1 6.2
Cortisol Low tryptophan .2 .1 N .50 N.S. High tryptophan .2 .09
NOTE: N = 25. ⁎ p ≤ .05. ⁎⁎ p ≤ .01.
105G. Lindseth et al. / Archives of Psychiatric Nursing 29 (2015) 102–107
Neumeister et al. (1998) achieved similar results with participants who had recovered from seasonal affective disorder and were served beverages with and without tryptophan. Transient recurrences of de- pressive symptoms resulted in the non-tryptophan group (Neumeister et al., 1998). The negative mood states because of lack of tryptophan in participants with a history of depressionwere consistentwith our re- search in that lower tryptophan consumption also led to depressed mood states. However, the Neumeister et al. study included participants with a history of depressive symptoms and our study was with healthy participants. Similarly, in a study by Spillmann et al. (2001) of formerly depressed patients, tryptophandepletionwas associatedwith increased depression and anxiety.
Our resultsfit with other evidence that dietary intervention can help mitigate depressive symptoms (Badrasawi et al., 2013; Fernstrom, 2013). Although the neurotransmitter serotonin has a role in mood al- terations and depression, central serotonin availability depends on the availability of its precursor tryptophan being made accessible to the central nervous system through the blood brain barrier. However, its precursor, tryptophan, can pass through the blood–brain barrier and is converted to serotonin in the presence of a vitamin B6 derivative (Dakshinamurti, Paulose, & Viswanathan, 1990; Shabbir et al., 2013). While many of the studies described in the literature did not indicate the role of vitamin B6 and its potential effect on their study outcomes, we controlled for possible micronutrient effects in our study by plan- ning all of the diets to meet the US RDA values, including vitamin B6. Our study also focused on the effects of higher doses of dietary trypto- phan on affective disorders unlike many of the published studies that focused on the effects of tryptophan depletion.
IMPLICATIONS FOR PRACTICE
Based on the findings from our study, recommendations can bemade for nursing practice. With the continued rise in mental health disparities, it seems important for nurses to provide information topatients related to health anddietary interventions that can decrease anxiety, irritability, and depression. The benefits of a diet for patients susceptible to affective dis- orders seem important since tryptophan—dense diets also improved mood and decreased symptoms of depression among depressed individ- uals in other studies (Badrasawi et al., 2013; Markus et al., 2008; Neumeister et al., 1998). However, the benefits in some of the studies re- sulted from a tryptophan supplement or manufactured nutrient powder (Markus et al., 2008; Neumeister et al., 1998).
Although study results suggest that tryptophan could be used as a remedy for improvement of affective disorders, considerations may also need to be taken before initiating tryptophan supplement treat- ments. For example, very high doses of up to 200 kg body weight/d of ingested tryptophan can result in side effects such as nausea, dizziness, and tremors when taken alone or in conjunction with serotonin en- hancement drugs (Fernstrom, 2012). In rare instances serotonin syn- drome, a condition in which individuals can present with more serious symptoms such as delirium or even coma, can result (Martin, 1996; Sternbach, 1991). Tryptophan supplementation taken in conjunc- tionwithmedications such asmonoamine oxidase inhibitors, for exam- ple, should also be used with caution. With the increasing use of selective serotonin reuptake inhibitor medications (e.g. Prozac or Zoloft) and, if used in combination with higher doses of tryptophan, could increase the risk of serotonin syndrome. More research is needed in order to understand the point at which side effects begin to occur when tryptophan is administered and at what dosage levels do signifi- cant side effects develop (Fernstrom, 2012).
The results of our study and other studies highlight the positive ef- fects that dietary tryptophan can have on symptoms of behavioral and depressive disorders (Badrasawi et al., 2013; Fernstrom, 2013; Markus et al., 2008; Neumeister et al., 1998). By concentrating on the positive effects of diet on affective processes, nurses can provide support for both healthy individuals and those at risk for affective disorders.
SUMMARY AND CONCLUSIONS
In summary, our study of healthy participants revealed that higher doses of dietary tryptophan resulted in significantly (p ≤ .05) less de- pression and irritability and decreased anxiety. This outcome differs, however, frommost of the existing research using tryptophan powders, tablets, capsules or supplementation rather than the effects of diet alone on depression, mood, or anxiety. Also of note, studies that focus on healthy participants are sparse. Our results are consistent with those of other studies in which dietary consumption of tryptophan produced notable effects in individualswith a history of behavioral and depressive disorders (Markus et al., 2008; Neumeister et al., 1998).
In conclusion, the results of our study indicated that increasing dietary intake of tryptophan may affect depression and mood scores of healthy participants resulting in less depressive symptoms andbettermood states whenmore tryptophanwas present in their diet. Also, consuming less di- etary tryptophan resulted in more irritability and anxiety in comparison towhen the same individuals consumedmore tryptophan.However, con- suming more tryptophan did not have a significant effect on salivary cor- tisol levels. Results of our studymay have limited generalizability because of the small, homogeneous sample; however, each participant did serve as their own control in this within-subjects designed study. Future work could be strengthened by using a placebo or comparison group. Given that few clinical studies have addressed the effects of dietary tryptophan consumption on affective disorders such asmood, depression and anxiety in healthy individuals, further research is recommended.
This researchwas supported in part by the U.S. Army Biomedical Re- search Grant Awards (DAMD17-03-1-0010 and W81XWH-10-1-0454) and National Institutes of Health (1C06 RR 022088–01).
Attenburrow, M. J., Williams, C., Odontiadis, J., Powell, J., Van de Ouderaa, F., Williams, M., et al. (2003). The effect of a nutritional source of tryptophan on dieting induced changes in brain 5-HT function. Psychological Medicine, 33, 1381–1386.
Badrasawi, M. M., Shahar, S., Abd, M. Z., & Haron, H. (2013). Effect of Talbinah food con- sumption on depressive symptoms among elderly individuals in long term care facil- ities, randomized clinical trial. Clinical Interventions in Aging, 8, 279–285, http://dx. doi.org/10.2147/CIA.S37586.
Booij, L., Merens, W., Markus, C. R., & Van der Does, A. W. (2006). Diet rich in α- lactalbumin improves memory in unmedicated recovered depressed patients and matched controls. Journal of Psychopharmacology, 20(4), 526–535.
Borenstein, M., Rothstein, H., & Cohen, J. (2001). Power and precision: A computer program for statistical power analysis and confidence intervals (Version 4) [Computer software]. Englewood Cliffs, NJ: Biostat, Inc.
Bowen, D. J., Spring, B., & Fox, E. (1991). Tryptophan and high-carbohydrate diets as ad- juncts to smoking cessation therapy. Journal of Behavioral Medicine, 14(2), 97–110.
Bucky, S. F., & Spielberger, C. D. (1973). State and trait anxiety in voluntary withdrawal of student naval aviators from flight training. Psychological Reports, 33, 351–354.
Campbell, M. H., Maynard, D., Roberti, J. W., & Emmanuel, M. K. (2012). A comparison of the psychometric strengths of the public-domain Zung Self-rating Depression Scale with the proprietary Beck Depression Inventory-II in Barbados. West Indian Medical Journal, 61(5), 483–488.
Chouinard, G., Young, S. N., & Annable, L. (1985). A controlled clinical trial of L-tryptophan in acute mania. Biological Psychiatry, 20(5), 546–557.
Dakshinamurti, K., Paulose, C. S., & Viswanathan, M. (1990). Vitamin B6 and hypertension. Annals of the New York Academy of Sciences, 585, 241–249.
Doenges (1989). Nursing care plans: Guidelines for planning patient care. Philadelphia: F.A. Davis, Co.
E.S.H.A. Research (2010). The Food Processor Nutrition Analysis Software (version 10.8) [Computer Software]. Salem, OR: ESHA Research.
Fernstrom, J. D. (1985). Dietary effects on brain serotonin synthesis: Relationship to appe- tite regulation. The American Journal of Clinical Nutrition, 42(5), 1072–1082.
Fernstrom, J. D. (2012). Effects and side effects associated with the non-nutritional use of tryptophan by humans. The Journal of Nutrition, 142(12), 2236s–2244s.
Fernstrom, J. D. (2013). Large neutral amino acids: Dietary effects on brain neurochemis- try and function. Amino Acids, 45(3), 419–430.
Food and Nutrition Board (1989). Recommended Dietary Allowances. National Academy of Sciences – National Research Council.
Gibson, R. (1990). Principles of Nutritional Assessment. New York: Oxford University Press. Hakkarainen, R., Partonen, T., Haukka, J., Virtamo, J., Albanes, D., & Lönnqvist, J. (2003). As-
sociation of dietary amino acids with lowmood. Depression and Anxiety, 18(2), 89–94.
106 G. Lindseth et al. / Archives of Psychiatric Nursing 29 (2015) 102–107
Markus, C. R., Firk, C., Gerhardt, C., Kloek, J., & Smolders, G. F. (2008). Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy vol- unteers. Psychopharmacology, 201(1), 107–114.
Markus, R., Panhuysen, G., Tuiten, A., & Koppeschaar, H. (2000). Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress. Physiology & Behavior, 70(3–4), 333–342, http://dx.doi.org/10.1016/S0031-9384 (00)00265-1.
Markus, C. R., Panhuysen, G., Tuiten, A., Koppeschaar, H., Fekkes, D., & Peters, M. L. (1998). Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cog- nitive performance of stress-prone subjects when subjected to a stressful task? Appetite, 31(1), 49–65.
Martin, T. G. (1996). Serotonin syndrome. Annals of Emergency Medicine, 28(5), 520–526. Mitchell, E., Slettenaar, M., Quadt, F., Giesbrecht, T., Kloek, J., Gerhardt, C., et al. (2011). Ef-
fect of hydrolysed egg protein on brain tryptophan availability. British Journal of Nutrition, 105(4), 611–617, http://dx.doi.org/10.1017/S0007114510004150.
Neumeister, A., Praschak-Rieder, N., Hesselmann, B., Vitouch, O., Rauh, M., Barocka, A., et al. (1998). Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychological Medicine, 28(2), 257–264.
Robinson, O. J., Cools, R., Crockett, M. J., & Sahakian, B. J. (2010). Mood state moderates the role of serotonin in cognitive biases. Journal of Psychopharmacology (Oxford, England), 24(4), 573–583.
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine de- pletion studies. Molecular Psychiatry, 12(4), 331–359.
Sakamoto, S., Kijima, N., Tomoda, A., & Kambara, M. (1998). Factor structures of the Zung Self‐Rating Depression Scale (SDS) for undergraduates. Journal of Clinical Psychology, 54(4), 477–487.
Shabbir, F., Patel, A., Mattison, C., Bose, S., Krishnamohan, R., Sweeney, E., et al. (2013). Ef- fect of diet on serotonergic neurotransmission in depression. Neurochemistry International, 62(3), 324–329, http://dx.doi.org/10.1016/j.neuint.2012.12.014.
Soh, N., & Walter, G. (2011). Tryptophan and depression: Can diet alone be the answer? Acta Neuropsychiatrica, 23(1), 3–11.
Spillmann, M. K., Van der Does, A. W., Rankin, M. A., Vuolo, R. D., Alpert, J. E., Nierenberg, A. A., et al. (2001). Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology, 155(2), 123–127.
Sternbach, H. (1991). The serotonin syndrome. The American Journal of Psychiatry, 148(6), 705–713.
Sylvia, L. G., Peters, A. T., Deckersbach, T., & Nierenberg, A. A. (2013). Nutrient-based ther- apies for bipolar disorder: A systematic review. Psychotherapy and Psychosomatics, 82 (1), 10–19, http://dx.doi.org/10.1159/000341309.
Watson, D., & Clark, L. A. (1994). The PANAS-X Manual for the Positive and Negative Affect Schedule—Expanded Form. Iowa City, IA: Department of Psychology, University of Iowa (Unpublished manuscript).
Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief mea- sures of Positive and Negative Affect: The PANAS Scales. Journal of Personality and Social Psychology, 54, 1063–1070.
Wurtman, R. J., & Wurtman, J. J. (1995). Brain serotonin, carbohydrate‐craving, obesity and depression. Obesity Research, 3(S4), 477S–480S.
Zung, W. W. (1965). A self-rating scale for depression. Archives of General Psychiatry, 12, 63–70, http://dx.doi.org/10.1001/archpsyc.1965.01720310065008.
Zung, W. W. (1967). Factors influencing the self-rating depression scale. Archives of General Psychiatry, 16(5), 543–547.
Zung, W. W. (1973). The measurement of affects: Depression and anxiety. Modern Problems of Pharmacopsychiatry, 7, 170–188.
Zung, W.W. (1986). Zung self-rating depression scale and depression status inventory. In T. A. Ban, & N. Sartorius (Eds.), Assessment of Depression (pp. 221–231). New York, NY: Springer Verlag, http://dx.doi.org/10.1007/978-3-642-70486-4_21.
Zung, W. W., Richards, C. B., & Short, M. J. (1965). Self-rating depression scale in an out- patient clinic. Further validation of the SDS. Archives of General Psychiatry, 13, 508–515.
107G. Lindseth et al. / Archives of Psychiatric Nursing 29 (2015) 102–107
The post The Effects of Dietary Tryptophan on Affective Disorders appeared first on Infinite Essays.